Delcath announces enrollment of first patient in ALIGN trial
Delcath Systems announces that patient treatments have begun in the Company’s second global US registration trial investigating Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System in the treatment of patients with intrahepatic cholangiocarcinoma. October 18, 2018